Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

• Status: Completed
• Trial end date: 2021-06-30
• Target enrollment: 0
• Participant gender: Female

Summary

To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Arkansas

Criteria

Inclusion Criteria:

• Documented endometrial cancer and scheduled for hysterectomy as part of their treatment.

• No known allergy to fluorescein dye

• Ability to understand and sign informed consent

• 18 years of age or older

Exclusion Criteria:

• Prior hysterectomy

• Known sensitivity to fluorescein dye